
Step 1: Start with what matters
See the current developments worth your attention.
Current affairs for UPSC
Not every headline deserves your time. Discover the stories that matter for UPSC, understand them beyond the headlines, and build the context, concepts, and perspective needed to think the UPSC way.
Relevance over volume
Analysis over summary
Recall over memorizing
Structured, not scattered
Built for the UPSC syllabus
The problem
Every day brings another headline, PDF, video or update. The hard part isn't finding information. It's knowing what deserves your time.
Still trying to figure out what actually matters for UPSC?
The shift
Keep the sources you already trust. Tattva filters them for UPSC, adds the context, and connects what you read to the syllabus and previous-year questions.
The shift
Before
A typical day looks like this.
Identify what truly matters.
Understand the bigger picture.
Connect information with concepts, schemas, data and PYQs.
Connect directly to the exam.
After
I know what matters.
Only the most relevant, UPSC-focused information.
I understand why.
Clear context, multiple perspectives and deeper analysis.
I know what to take forward.
Actionable insights for your preparation.

How it works

See the current developments worth your attention.

See why a development matters for UPSC and where it connects to your preparation.

Go beyond the headline to understand the context, concepts and connections.

Use what you learn to strengthen your existing UPSC preparation rather than simply adding another source to consume.
Proof
One real story from a recent edition, opened up.
The news
In his Independence Day address, Prime Minister Narendra Modi urged Indian pharmaceutical firms to aim for a place among the world’s top five, signalling a policy push for the sector to move beyond generic medicines toward novel drug discovery and development.
From generics
to global
innovation.
A stronger,
healthier
India.
This call is more than aspirational rhetoric; it reflects a structural transition in India’s pharma landscape. Over the past decade, the industry, which already ranks third globally by volume, is increasingly investing in biologics, cell and gene therapies, and AI‑driven molecule design.
India’s pharmaceutical sector is the world’s third‑largest by volume, with more than 3,000 companies and 10,500 manufacturing units, yet it is only the 11th by value, reflecting a dominance of low‑margin generics.
Discuss the challenges and opportunities faced by the Indian pharmaceutical industry in moving from generic drug manufacturing to novel drug discovery.
Examine the role of artificial intelligence in enhancing research and development in biotechnology.
The trajectory from a generic‑drug powerhouse to a global laboratory of innovative therapeutics illustrates how AI, targeted policy instruments like the Biopharma Shakti Mission, and strategic national ambitions intertwine.
Our blogs
Library in progress · examples





Stop spending your study time figuring out what matters. See what's worth knowing. Understand why it matters. Learn what to take forward.